Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - RETAINED EARNINGS
Retained Earnings KALV - KalVista Pharmaceuticals, Inc.
-470 M
LAST VALUE
-37.03%
2 YEAR CAGR
-38.41%
5 YEAR CAGR
-29.87%
10 YEAR CAGR